CFDA

Cell therapy company, Cytori Therapeutics Inc (NASDAQ: CYTX) has had a lot to celebrate recently. Cytori CEO Dr. Marc Hedrick spoke with Benzinga about the news and about the small San Diego medical technology company he heads. Related: Cytori Receives Positive European Opinion on Orphan Drug...

In an exclusive interview with Benzinga, director of Investor Relations, Helen Yang, discussed Sinovac’s (NASDAQ: SVA) future opportunities. Sinovac is Chinese biopharmaceutical company which produces, among others, a hepatitis A and B vaccine and is currently preparing to commercialize...